Viewing Study NCT06824103


Ignite Creation Date: 2025-12-24 @ 7:10 PM
Ignite Modification Date: 2026-01-01 @ 11:48 PM
Study NCT ID: NCT06824103
Status: RECRUITING
Last Update Posted: 2025-11-26
First Post: 2025-02-04
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Efficacy and Safety of Ruxolitinib in Chinese Participants With Corticosteroid-refractory Chronic Graft vs. Host Disease
Sponsor:
Organization:

Study Design

Study Type: INTERVENTIONAL
Expanded Access Type Individual: None
Expanded Access Type Intermediate: None
Expanded Access Type Treatment: None
Patient Registry: None
Target Duration: None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention: None
Bio Spec Description: None
Enrollment Count:
Enrollment Type:
Design Primary Purpose:
Design Masking:
Phases:

Phases

Phase Brief Phase Text View
None PHASE4 View
Observational Models:
Time Perspective List:
Who Masked List: